Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2332 to 2381 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
229.258\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
230.294\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00452\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitous tropomodulin (u-tmod) (tropomodulin 3). [source:swissprot;acc:q9nyl9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tropomodulin 1 (erythrocyte tropomodulin) (e-tmod). [source:swissprot;acc:p28289]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal tropomodulin (n-tmod) (tropomodulin 2). [source:swissprot;acc:q9nzr1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-2. [source:swissprot;acc:q07687]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-5. [source:swissprot;acc:p56178]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fetal brain protein 239 (239fb). [source:swissprot;acc:q15777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-3. [source:swissprot;acc:o60479]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activated p21cdc42hs kinase. [source:refseq;acc:nm\_005781]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 2 isoform 1; tak1-binding protein 2. [source:refseq;acc:nm\_015093]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycine cleavage system h protein, mitochondrial precursor. [source:swissprot;acc:p23434]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.222\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00451\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.878\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.893\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0045\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.057\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00448\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibulin-1 precursor. [source:swissprot;acc:p23142]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.503\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytosolic nonspecific dipeptidase (glutamate carboxypeptidase-like protein 1). [source:swissprot;acc:q96kp4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.811\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.733\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptotagmin xii (sytxii). [source:swissprot;acc:q8iv01]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.223\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00438\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.088\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.155\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00436\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
182.232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
183.027\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 2 (ec 3.6.3.4) (copper pump 2) (wilson disease-associated protein). [source:swissprot;acc:p35670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.078\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 7 (26s proteasome regulatory subunit s12) (proteasome subunit p40) (mov34 protein homolog). [source:swissprot;acc:p51665]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00426\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 g2 (ec 6.3.2.19) (ubiquitin-protein ligase g2) (ubiquitin carrier protein g2). [source:swissprot;acc:p56554]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
198.181\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
197.346\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00423\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
38 kda fk-506 binding protein homolog (fkbpr38) (fk506-binding protein 8). [source:swissprot;acc:q14318]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate kinase, testis specific (ec 2.7.2.3). [source:swissprot;acc:p07205]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.196\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.056\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00415\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (neural enolase) (nse) (enolase 2). [source:swissprot;acc:p09104]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
207.186\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
208.046\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (skeletal muscle enolase) (mse) (enolase 3). [source:swissprot;acc:p13929]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate kinase 1 (ec 2.7.2.3) (primer recognition protein 2) (prp 2). [source:swissprot;acc:p00558]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.178\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.037\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (non- neural enolase) (nne) (enolase 1) (phosphopyruvate hydratase). [source:swissprot;acc:p06733]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.046\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transaldolase (ec 2.2.1.2). [source:swissprot;acc:p37837]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.816\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.697\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00414\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate carboxypeptidase-like protein 2 precursor. [source:swissprot;acc:q96kn2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.958\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14.5 kda translational inhibitor protein (p14.5) (uk114 antigen homolog). [source:swissprot;acc:p52758]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.353\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.529\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00407\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.589\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.475\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 1 (26s proteasome regulatory subunit s1) (26s proteasome subunit p112). [source:swissprot;acc:q99460]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.555\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.434\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00402\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adhesion regulating molecule 1 precursor (110 kda cell membrane glycoprotein) (gp110). [source:swissprot;acc:q16186]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin carboxyl-terminal hydrolase isozyme l5 (ec 3.4.19.12) (uch- l5) (ubiquitin thiolesterase l5) (ubiquitin c-terminal hydrolase uch37) (cgi-70) (ad-019). [source:swissprot;acc:q9y5k5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna polymerase ii subunit 5-mediating protein (rpb5-mediating protein). [source:swissprot;acc:o94763]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 2 (smad 2) (mothers against dpp homolog 2) (mad-related protein 2) (hmad-2) (jv18-1) (hsmad2). [source:swissprot;acc:q15796]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.724\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.574\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.004\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 1 (smad 1) (mothers against dpp homolog 1) (mad-related protein 1) (transforming growth factor- beta signaling protein-1) (bsp-1) (hsmad1) (jv4-1). [source:swissprot;acc:q15797]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 subunit 6 (mov34 homolog, 34 kd). [source:refseq;acc:nm\_006833]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 3 (smad 3) (mothers against dpp homolog 3) (mad3) (hmad-3) (mmad3) (jv15-2) (hsmad3). [source:swissprot;acc:q92940]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 11 (hd11). [source:swissprot;acc:q96db2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ethanolamine kinase-like protein eki2 (flj10761). [source:swissprot;acc:q9nvf9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ethanolamine kinase (ec 2.7.1.82) (eki). [source:swissprot;acc:q9hbu6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma susceptibility protein; x 003 protein; hdcmc29p; hspc260; likely ortholog of mouse cd40 ligand-activated specific transcript 3 (clast3). [source:refseq;acc:nm\_020232]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 5; jun activation domain-binding protein. [source:refseq;acc:nm\_006837]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 9 (smad 9) (mothers against dpp homolog 9) (smad9) (madh6). [source:swissprot;acc:o15198]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/